Exploring the Prognosis of Breast Cancer with Synchronous Distant Nonregional Lymph Node Metastasis and Establishing a Predictive Model: A Population-Based Study

Figure 5

Nomogram to predict the 1-year, 3-year, and 5-year OS for breast cancer patients with SDLNM. OS: overall survival; Her2: human epidermal growth factor receptor type 2; HR: hormone receptor; TNBC: triple-negative breast cancer; SDLNM: synchronous isolated metastatic distant lymph node metastasis.